You are currently viewing a new version of our website. To view the old version click .

Oncogenic Signaling Pathways in Cancer

This special issue belongs to the section “Cancer Biology and Oncology“.

Special Issue Information

Dear Colleagues:

This Special Issue, "Oncogenic Signaling Pathways in Cancer", focuses on the oncogenic roles of different signaling pathways among cancers. Signaling pathways are essential to modulate various intracellular metabolic steps for normal physiological functions in cells. However, an abnormality of any signaling pathway triggering irregular cell proliferation could result in cancer development and progression. Thus, revealing the mechanism of oncogenic signaling pathway in cancer is important for therapeutic purposes. Accordingly, all investigations of signaling pathway(s), single or multiple and/or with crosstalk, at the cellular, molecular and genetic levels related to cancer events plus drug and/or molecule designs for cancer treatments are graciously invited, in the form of original research or review articles covering this significant and fast-growing field of biomedicine.

Prof. Dr. Bu-Miin Huang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oncogenic
  • signaling pathway
  • crosstalk
  • cancer
  • cell proliferation
  • biomedicine
  • therapeutic

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomedicines - ISSN 2227-9059